key articles
Photoselective vaporization of the prostate (GreenLight PV): lessons learnt after 3500 procedures - A review
Tuesday, 28 August 2007 - Benign prostatic hyperplasia (BPH) is a very common condition in the ageing male. A number of minimally invasive procedures have been developed with the objective of matching or increasing the efficacy...
Authors: Gomez et al.
Does intraprostatic inflammation have a role in the pathogenesis and progression of benign prostatic hyperplasia?
Monday, 13 August 2007 - Acute and/or chronic intraprostatic inflammation (ACI) is often related with pathogenesis and progression of benign prostatic hyperplasia (BPH), and urinary retention is considered an endpoint in the...
Authors: Mishra et al.
Managing the progression of lower urinary tract symptoms/benign prostatic hyperplasia: therapeutic options for the man at risk - a mini review
Monday, 13 August 2007 - In benign prostatic hyperplasia (BPH), increased prostate volume has been shown to be associated with future symptom deterioration and progression to acute urinary retention (AUR) or BPH-related surgery....
Authors: Emberton et al.
Prediction of α1-Adrenoceptor Occupancy in the Human Prostate from Plasma Concentrations of Silodosin, Tamsulosin and Terazosin to Treat Urinary Obstruction in Benign Prostatic Hyperplasia
Sunday, 12 August 2007 - α1-Adrenoceptor antagonists are clinically useful for the improvement of urinary obstruction due to benign prostatic hyperplasia (BPH), and their therapeutic effects are mediated through the blockade of...
Authors: Yamada et al.
Intravesical Prostatic Protrusion is Better Than Prostate Volume in Predicting the Outcome of Trial Without Catheter in White Men Presenting With Acute Urinary Retention: A Prospective Clinical Study
Thursday, 2 August 2007 - Benign prostatic hyperplasia in the aging male is a progressive condition associated with worsening of lower urinary tract symptoms (LUTS), the need for prostatic surgery and acute urinary retention...
Authors: Mariappan et al.
Modifiable Risk Factors for Benign Prostatic Hyperplasia and Lower Urinary Tract Symptoms: New Approaches to Old Problems
Thursday, 2 August 2007 - Benign prostatic hyperplasia (BPH) is a substantial challenge to public health. BPH is generally not regarded as a preventable disease. However, accumulating evidence suggests that modifiable factors may...
Author: Parsons
Advances in the medical management of benign prostatic hyperplasia
Friday, 20 July 2007 - Benign prostatic hyperplasia (BPH) is an inevitable part of aging. Its conditions include progressive bothersome voiding symptoms (now termed lower urinary tract symptoms instead of prostatism) that trigger...
Authors: Jewett et al
Effects of doxazosin on prostate, bladder and penile function
Monday, 16 July 2007 - Hypertension may impact pelvic arterial blood flow resulting in reduction of nitric oxide synthase (NOS) levels. Although doxazosin, an alpha(1)-adrenoceptor antagonist, has been shown to improve erectile...
Authors: Yono et al
Combination therapy in patients with benign prostatic hyperplasia - a review
Monday, 16 July 2007 - Trials of monotherapy with a-adrenergic-receptor antagonists (aARAs) and 5a-reductase inhibitors (5ARIs) have found that the former drug class is effective in managing benign prostatic hyperplasia...
Authors: McVary
Should patients with symptomatic BPH have a trial of medical therapy by their general practitioner prior to referral for urological assessment?
Friday, 13 July 2007 - The British Association of Urological Surgeons (BAUS) has recently recommended guidelines for the management of Lower Urinary Tract Symptoms (LUTS) by general practitioners outlining the indications for...
Authors: McGuire et al
